BioDrain Medical Inc. (“BMI”) is focused on the development of innovative products that safely dispose of fluids generated from surgical procedures. Its patented, FDA cleared Streamway™ System provides hospitals and ambulatory surgical centers (ASCs) with an automatic, efficient and cost-reducing means to safely dispose of potentially infectious fluids (eg. blood) generated in operating rooms (“ORs”). The Streamway™ System protects hospital workers from exposure to such fluids, reduces handling costs, improves hospitals’ regulatory compliance, and is environmentally friendly. Since receiving FDA clearance, the Company has completed beta testing and has scheduled customer evaluations. BMI is now in the product launch phase.
Operative Fluid Management Market
The existing fluid disposal process in the OR utilizes manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters. The use of canisters presents several environmental issues; they are not biodegradable, carry large disposal costs and take up landfill space. In addition, emptying these canisters is an exposure risk and very labor intensive. Hospitals generate over two million tons of waste each year. Given the fact that the majority of this waste is disposed through the antiquated canister approach, a strong market need exists for a safer and more efficient solution.’
BioDrain’s Streamway™ system fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational Safety and Health Administration (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).